The European Commission said Wednesday it had forced South African drugs giant Aspen to slash prices on six cancer drugs after finding it abused its market dominance to hike charges.
The firm agreed to cut the cost of the medicines, used for the treatment of some forms of blood cancer including leukaemia, by some 73 percent inside the EU, after a years-long probe.
“Aspen’s commitments will save European health systems many dozens of million euros and will ensure that these crucial medicines remain available,” European Commission competition chief Margrethe Vestager said.
“Today’s decision gives a strong signal to other dominant pharmaceutical companies not to engage in abusive pricing practices to exploit our health systems.”
The European Commission, the EU’s executive arm, launched an investigation back in 2017 after Aspen increased prices of some of its medicines by several hundred percent.
The case was the Commission’s first investigation into allegations of excessive pricing practices in the pharmaceutical industry.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI